Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Kenichi Ogiwara, MD, PhD, Keiko Shinozawa, PhD, Keiji Nogami, MD, PhD, Tomoko Matsumoto, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Koji Yada, MD, Katsuyuki Fukutake, MD, PhD, Midori Shima, MD, PhD

Blood (2011) 118 (21): 537.

https://doi.org/10.1182/blood.V118.21.537.537

Published: 2011

Journal Articles

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Katsumi Nishiya, MD, PhD, Ichiro Tanaka, MD, PhD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Koji Yada, MD, Tomoko Matsumoto, Midori Shima, MD, PhD

Blood (2011) 118 (21): 3320.

https://doi.org/10.1182/blood.V118.21.3320.3320

Published: 2011

Journal Articles

Tissue Factor Pathway Inhibitor Causes Unresponsiveness to Activated Prothrombin Complex Concentrates for Hemophilia A Patients with Inhibitors.

Kenichi Ogiwara, MD, Keiji Nogami, MD, PhD, Ichiro Tanaka, MD, PhD, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Midori Shima, MD, PhD

Blood (2010) 116 (21): 3663.

https://doi.org/10.1182/blood.V116.21.3663.3663

Published: 2010

Journal Articles

Procoagulant Activity of Antifibrinolytic Agents; A Novel Hemostatic Mechanism of Tranexamic Acid and Epsilon-Aminocaproic Acid.

Kenichi Ogiwara, MD, Keiji Nogami, MD, PhD, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Midori Shima, MD, PhD

Blood (2010) 116 (21): 1151.

https://doi.org/10.1182/blood.V116.21.1151.1151

Published: 2010

Journal Articles

Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII.

Koji Yada, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama, Midori Shim

Blood (2009) 114 (22): 3169.

https://doi.org/10.1182/blood.V114.22.3169.3169

Published: 2009

Journal Articles

Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation.

Kenichi Ogiwara, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama, Midori Shima

Blood (2009) 114 (22): 3177.

https://doi.org/10.1182/blood.V114.22.3177.3177

Published: 2009

Journal Articles

Determination for Coagulation Functions and Novel Inhibitory Mechanisms in Acquired Hemophilia A with Type 2 Inhibitors.

Tomoko Matsumoto, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama, Midori Shima

Blood (2009) 114 (22): 3483.

https://doi.org/10.1182/blood.V114.22.3483.3483

Published: 2009

Journal Articles

Mechanisms of Human Neutrophil Elastase-Catalyzed Inactivation of the Factor VIII(a).

Katsumi Nishiya, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima

Blood (2009) 114 (22): 2125.

https://doi.org/10.1182/blood.V114.22.2125.2125

Published: 2009

Journal Articles

Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner

Kenichi Ogiwara, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya, Midori Shima

Blood (2008) 112 (11): 1028.

https://doi.org/10.1182/blood.V112.11.1028.1028

Published: 2008

Journal Articles

Identification of a Factor IXa-Interactive Site within the C2 Domain of Factor VIIIa and a Crucial Role of These Associations for the Process of Clot Formation

Tetsuhiro Soeda, Keiji Nogami, Kenichi Ogiwara, Masahiro Takeyama, Katsumi Nishiya, Midori Shima

Blood (2008) 112 (11): 1035.

https://doi.org/10.1182/blood.V112.11.1035.1035

Published: 2008

Journal Articles

Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation

Tetsuhiro Soeda, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya, Midori Shima

Blood (2008) 112 (11): 1036.

https://doi.org/10.1182/blood.V112.11.1036.1036

Published: 2008

Journal Articles

Lysine-Binding Site-Dependent Interaction with Plasmin and Factor Va Responsible for Plasmin-Catalyzed Factor Va Inactivation.

Katsumi Nishiya, Keiji Nogami, Kiyotaka Okada, Osamu Matsuo, Kenichi Ogiwara, Midori Shima

Blood (2008) 112 (11): 2016.

https://doi.org/10.1182/blood.V112.11.2016.2016

Published: 2008

Journal Articles

Localization of Factor VIII Interactive Site within Plasmin/Plasminogen Which Is Responsible for Plasmin-Catalyzed Activation/Inactivation of Factor VIII.

Katsumi Nishiya, MD, Keiji Nogami, M.D., Kiyotaka Okada, M.D., Osamu Matsuo, M.D., Masahiro Takeyama, M.D., Kenichi Ogiwara, M.D., Ichiro Tanaka, M.D., Akira Yoshioka, M.D., Midori Shima, M.D.

Blood (2007) 110 (11): 1759.

https://doi.org/10.1182/blood.V110.11.1759.1759

Published: 2007

Journal Articles

Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII.

Keiji Nogami, MD, PhD, Midori Shima, MD, PhD, Tomoko Matsumoto, Katsumi Nishiya, MD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Ichiro Tanaka, MD, PhD, Akira Yoshioka, MD, PhD

Blood (2005) 106 (11): 1017.

https://doi.org/10.1182/blood.V106.11.1017.1017

Published: 2005

Journal Articles

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Keiji Nogami, MD, PhD, Midori Shima, MD, PhD, Katsumi Nishiya, MD, Evgueni L. Saenko, PhD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Ichiro Tanaka, MD, PhD, Akira Yoshioka, MD, PhD

Blood (2005) 106 (11): 1018.

https://doi.org/10.1182/blood.V106.11.1018.1018

Published: 2005

Journal Articles

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivation

Keiji Nogami, Midori Shima, Katsumi Nishiya, Kazuya Hosokawa, Evgueni L. Saenko, Yoshihiko Sakurai, Masaru Shibata, Hiroshi Suzuki, Ichiro Tanaka, Akira Yoshioka

Blood (2002) 99 (11): 3993–3998.

https://doi.org/10.1182/blood.V99.11.3993

Published: 2002

NARROW

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Tissue Factor Pathway Inhibitor Causes Unresponsiveness to Activated Prothrombin Complex Concentrates for Hemophilia A Patients with Inhibitors.

Procoagulant Activity of Antifibrinolytic Agents; A Novel Hemostatic Mechanism of Tranexamic Acid and Epsilon-Aminocaproic Acid.

Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII.

Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation.

Determination for Coagulation Functions and Novel Inhibitory Mechanisms in Acquired Hemophilia A with Type 2 Inhibitors.

Mechanisms of Human Neutrophil Elastase-Catalyzed Inactivation of the Factor VIII(a).

Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner

Identification of a Factor IXa-Interactive Site within the C2 Domain of Factor VIIIa and a Crucial Role of These Associations for the Process of Clot Formation

Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation

Lysine-Binding Site-Dependent Interaction with Plasmin and Factor Va Responsible for Plasmin-Catalyzed Factor Va Inactivation.

Localization of Factor VIII Interactive Site within Plasmin/Plasminogen Which Is Responsible for Plasmin-Catalyzed Activation/Inactivation of Factor VIII.

Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII.

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only